The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the ... enters an increasingly crowded IBD drug market following the approval of rival ...
inflammatory bowel disease, pancreatitis, underlying medical conditions, overeating, consuming non-food objects, and ...